The primary staging of high-risk PCa patients is conducted with PSA levels of ≥20 ng/mL, a Gleason score ≥ 8 and a clinical stage of T3/T4 (extraprostatic extension/seminal vesicle invasion). The gene discussed is KLK3; the disease is posterior cortical atrophy.